Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerular Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00404833
What this trial is testing

Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental

Who this might be right for
Glomerulonephritis, MembranousGlomerulosclerosis, Focal
Hospital Authority, Hong Kong 16
Post-approval studies (Phase 4)Study completedNCT02351752
What this trial is testing

Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study

Who this might be right for
Primary IgA Nephropathy
LLiu 20
Early research (Phase 1)Study completedNCT05505955
What this trial is testing

Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency

Who this might be right for
Glomerulonephritis
Chengdu Suncadia Medicine Co., Ltd. 83
Large-scale testing (Phase 3)Looking for participantsNCT07014826
What this trial is testing

A Trial of HRS-5965 Capsule in Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Chengdu Suncadia Medicine Co., Ltd. 378
Not applicableEnded earlyNCT01602835
What this trial is testing

Human Urine Sample Collection for Alport Nephropathy Biomarker Studies

Who this might be right for
Alport Syndrome
Novartis Pharmaceuticals 80
Not applicableNot Yet RecruitingNCT07805863
What this trial is testing

Serum MPO-DNA Complexes as a Biomarker of Disease Activity in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Assiut University 90
Testing effectiveness (Phase 2)Looking for participantsNCT06047171
What this trial is testing

Rescue of Nephrons With ALE.F02 (RENAL-F02)

Who this might be right for
Glomerulonephritis Rapidly Progressive
Alentis Therapeutics AG 80
Not applicableStudy completedNCT00302549
What this trial is testing

To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN

Who this might be right for
Lupus Nephritis
Nanjing University School of Medicine 61
Large-scale testing (Phase 3)WithdrawnNCT00599963
What this trial is testing

Paricalcitol for the Treatment of Immunoglobulin A Nephropathy

Who this might be right for
IgA Nephropathy
Chinese University of Hong Kong
Early research (Phase 1)Looking for participantsNCT06975787
What this trial is testing

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Regeneron Pharmaceuticals 90
Testing effectiveness (Phase 2)Study completedNCT06835322
What this trial is testing

Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis

Who this might be right for
Glomerulonephritis
Alexandria University 100
Testing effectiveness (Phase 2)Ended earlyNCT05941845
What this trial is testing

Interferon Alfa Therapy Based on Th17 Profile in Membranous Nephropathy

Who this might be right for
Membranous Nephropathy
Centre Hospitalier Universitaire de Nice 4
Not applicableUnknownNCT05082363
What this trial is testing

The Expression Profile of New Complement Components in Childhood Lupus Nephritis

Who this might be right for
Lupus Nephritis
Assiut University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06581198
What this trial is testing

Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
Novartis Pharmaceuticals 179
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07474636
What this trial is testing

Efficacy and Safety Study of HS-10542 for IgA Nephropathy

Who this might be right for
IgANImmunoglobulin A Nephropathy (IgAN)Glomerular Disease
Jiangsu Hansoh Pharmaceutical Co., Ltd. 90
Large-scale testing (Phase 3)Study completedNCT00135967
What this trial is testing

Mycophenolate Mofetil in Membranous Nephropathy

Who this might be right for
Glomerulonephritis, Membranous
Radboud University Medical Center 30
Early research (Phase 1)Looking for participantsNCT07085104
What this trial is testing

Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Who this might be right for
Systemic Lupus Erythematosus (With and Without Nephritis)Idiopathic Inflammatory MyopathySystemic Sclerosis
Allogene Therapeutics 66
Testing effectiveness (Phase 2)UnknownNCT01226147
What this trial is testing

Efficacy and Safety of Tamibarotene(AM80) for Lupus Nephritis

Who this might be right for
Lupus Nephritis
Kinki University 20
Not applicableUnknownNCT01879514
What this trial is testing

Study of Standardized Treatment of Integrative Medicine With the Severe IgA Nephropath

Who this might be right for
IgA Nephropathy
Shanghai University of Traditional Chinese Medicine 200
Large-scale testing (Phase 3)Looking for participantsNCT05795140
What this trial is testing

Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Novartis Pharmaceuticals 65
Next Page